Diabetes Mellitus, Type 2  >>  Adlyxin (lixisenatide)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Adlyxin (lixisenatide) / Sanofi
RESTORE, NCT00931372: Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2

Completed
1
22
Europe
Lixisenatide (AVE0010), Placebo
Sanofi, Profil GmbH, Neuss, Germany
Diabetes Mellitus, Type 2
08/09
08/09
NCT01572649 / 2011-004584-67: Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes

Completed
1
24
US, Europe, RoW
Lixisenatide (AVE0010), Placebo
Sanofi
Type 2 Diabetes Mellitus
03/14
03/14

Download Options